Although human B19 parvovirus infection has been clearly associated with a number of distinct syndromes (including severe anemia, abortion, and arthritis), detailed knowledge of its pathogenesis has been hindered by the lack of a suitable animal model. We have identified a novel simian parvovirus in cynomolgus monkeys with severe anemia. Sequencing of a 723-bp fragment of cloned viral DNA extracted from serum revealed that the simian parvovirus has 65% homology at the DNA level with the human B19 parvovirus but little homology with other known parvoviruses. Light microscopic examination of bone marrow from infected animals showed intranuclear inclusion bodies, and ultrastructural studies showed viral arrays characteristic of parvoviruses. Another striking feature was the presence of marked dyserythropoiesis in cells of the erythroid lineage, raising the possibility that B19 parvovirus infection may underlie related dyserythropoietic syndromes in human beings. Affected animals had concurrent infection with the immunosuppressive type D simian retrovirus, analogous to HIV patients who develop severe anemia because of infection with B19 parvovirus. The remarkable similarities between the simian and B19 parvoviruses suggest that experimentally infected cynomolgus monkeys may serve as a useful animal model of human B19 infection. (J. Clin. Invest. 1994. 93:1571-1576
Introduction
The Parvoviridae family comprises a group of single-stranded DNA viruses that are the smallest known viruses that infect mammalian cells (1) . Some are important pathogens of human beings and animals, particularly human B19 parvovirus and the canine, feline, and porcine parvoviruses. A key feature of the Parvoviridae is their requirement for actively dividing cells in order to replicate. As such, the characteristic pathogenesis of diseases caused by parvoviruses involves cytotoxicity of tissues with high cellular turnover, particularly the intestine (canine and feline viruses), developing fetus (human B19, feline, and porcine parvoviruses), and bone marrow (human B19, canine, and feline viruses). Nonetheless, the spectrum of clinical disease (skin rash, anemia, fetal loss, or arthritis) associated with B 19 parvovirus infections differs from that of other mammalian parvoviruses (2) . Also, in contrast to other mammalian parvoviruses B 19 is difficult to culture. It will not replicate in established cell lines but requires explant cultures of bone marrow or human fetal liver cells for in vitro studies. A low degree of homology further reflects major differences between B 19 and other mammalian parvoviruses. An animal model of human B 19 parvovirus infection may contribute to our understanding of the pathogenesis of infection in human beings, especially fetal transmission and congenital infection.
We report here the isolation of a new simian parvovirus (SPV)' that shares a high homology with B 19 parvovirus at the DNA level and is remarkably similar to the human B 19 parvovirus in its predilection for bone marrow and ability to cause severe anemia.
Methods
Animal population. The Comparative Medicine Clinical Research Center (CMCRC) of the Bowman Gray School of Medicine has 1,500 monkeys that are used in comparative clinical trials ofatherosclerosis and osteoporosis. This population consists predominantly of cynomolgus monkeys (-1,200) , with smaller numbers of rhesus (-200) and some stump-tailed macaques.
Light and electron microscopy. For light microscopy, tissues were fixed in 10% neutral buffered formalin, dehydrated through alcohols, embedded in paraffin, and 6-jsm sections were stained with hematoxylin and eosin. For electron microscopy, tissues were fixed in 0.1 M cacodylate buffer containing 1% glutaraldehyde, postfixed in 1% OsO4, dehydrated, and embedded in Epon before sectioning. Tissues were examined with an electron microscope (EM 400; Philips Technologies, Cheshire, CT).
Virological and molecular studies. Serum and tissue samples (spleen, lymph nodes, bone marrow) collected at necropsy were submitted for virus isolation by standard methods, including isolation of simian type D simian retrovirus, as determined by formation ofcharacteristic syncytial cells in coculture with the lymphoblastoid Raji cell line (3, 4) .
1. Abbreviations used in this paper: CDA, congenital dyserythropoietic anemias; CMCRC, Comparative Medicine Clinical Research Center; SPV, simian parvovirus. Parvoviral DNA was detected by dot-blot hybridization of DNA from 10 ,l of serum prepared as previously described for human serum (5) using a 32P nick-translated full-length B19 parvovirus probe (pYT103) (6) .
To further characterize a putative SPV, the virus was concentrated by layering 2 ml of serum over 3 ml of 20% sucrose and centrifuging at 150,000 g for 5 h. The pellet was resuspended in 50 1Al of Tris-EDTA buffer (pH 7.5). Single-stranded DNA was extracted using silica (7) and allowed to self-anneal by incubating the DNA in 50 mM saline at 500C for 16 h. Southern analysis on the single-stranded and annealed DNA was performed using the pYT 103 probe (8) .
Sequence data were obtained by cloning a fragment of the DNA into a pUC19 vector. The annealed DNA was digested with the restriction enzyme PstI, and the products were analyzed on a 0.9% agarose gel. A 723-bp fragment was cut from the gel, the DNA purified by GeneClean (Bio 101, La Jolla, CA), and ligated into the Pst I site of pUC 19. The inserted DNA was sequenced by the dideoxy method using Sequenase II (U. S. Biochem. Corp., Cleveland, OH); initially "universal" M 13 forward and reverse primers were used, and then primers were designed from the previously obtained sequence. The insert was fully sequenced in both directions and the sequence obtained was analyzed using DNAStar (DNAStar Inc., Madison, WI).
To confirm that the sequence was present in the affected animals, a PCR assay was designed using primers and an internal probe from the sequence of the cloned insert. These primers (nucleotides 60-79, 676-657) and this probe (nucleotides 497-515) detect a 616-nucleotide fragment from the insert that is absent in B19 parvovirus. Serum samples were analyzed using a modification of the PCR method for B19 parvovirus (9) ; product detection was by Southern transfer of agarose gel electrophoresis onto a nylon membrane and probing with the 32P end-labeled internal probe.
Results
Clinical observations. A cluster of five adult male cynomolgus monkeys with anemia was identified in 1992 at the CMCRC. All had been healthy when living in single cages during the year before their transfer into group housing. After 6 wk, the group offive was disbanded and mixed with other monkeys ("in-contacts," 13 animals in total) to form new social groups. At this time, one monkey (monkey no. 2) was observed to be ill, with clinical signs consisting of diarrhea, dehydration, and moderate anemia (hemoglobin 7.4, hematocrit 29) that progressed over the course of a week (hemoglobin 3.8, hematocrit 19) . Despite a blood transfusion, this animal became moribund and was euthanized because of the grave prognosis.
Over the subsequent 4 wk, three of the remaining four monkeys (nos. 1, 3, and 4) constituting the original group became ill with severe normocytic normochromic anemia (Table  I ). Monkey no. 5 was apparently healthy, with hematological findings that were close to normal (Table I) , and this monkey remains healthy to date. Monitoring of hematological parameters in the 13 in-contacts resulted in the recognition of anemia in two additional monkeys (nos. 6 and 7) that were euthanized to limit possible spread ofdisease. The anemia was classified as predominantly normocytic, normochromic, and nonregenerative, although the presence of reticulocytes indicated erythroid regeneration in two monkeys. Whereas anemia was the major finding (6/6 animals) prompting a decision of euthanasia, a high percentage of monkeys also had diarrhea, dehydration, and positive fecal cultures for Campylobacter spps (3/4 monkeys).
Pathological findings. Gross necropsy findings revealed moderate to marked splenomegaly (6 / 6 monkeys) and moder- (4/6 monkeys) and myeloid lineages, the presence of many medium to large undifferentiated cells, and increased numbers of megakaryocytes. A frequent finding in bone marrows with less marked erythroid depletion was the presence of markedly abnormal cells of erythroid lineage characterized by bizarre nuclear forms, including nuclear blebbing, appendages, or multilobulation (Fig. 1) . The other striking finding in some marrows was the presence of intranuclear inclusion bodies, with morphologic characteristics consistent with those observed in tissues infected with Bi 9 and other parvoviruses (10) (11) (12) (Fig. 1) . Intranuclear inclusion bodies were present in medium to large, less differentiated cells as well as more mature elements of the erythroid series such as normoblasts. They were present in large numbers in one marrow (sometimes as many as five or more per high-powered field; X 100 oil immersion objective), and were observed in small numbers or were rare in the other marrows. Ultrastructural examination of inclusions revealed the presence of -24-nm virus particles and an occasional viral array characteristic of parvoviruses ( 1 1-14) (Fig. 1) (3, 4, (15) (16) (17) . A mononuclear cell culture from a blood sample obtained from the healthy monkey (no. 5) also tested positive for type D simian retrovirus. Serum neutralization tests confirmed the presence of serotype 2 in three of three isolates examined.
Parvovirusfindings. Serum samples from the four anemic monkeys (nos. 1-4) ofthe original group offive tested strongly positive by dot blot hybridization for parvoviral DNA (Fig. 2) . The sample from the healthy monkey (no. 5) was negative.
DNA from the serum of monkey no. 1 was extracted and examined further. Analysis by agarose gel electrophoresis confirmed that the DNA migrated at the same position as singlestranded Bl9 DNA and cross-hybridized to a B19 probe (pYT 103). Incubation ofthe DNA in low salt solution at 500C converted all single-stranded DNA to double-stranded DNA that migrated as a 5.4-5.5-kb band, suggesting that the virus produced equimolar complementary single strands that selfanneal (as for B 19 parvovirus) ( 18) .
Analysis of the fragment cloned into a pUCl9 vector showed homology (64.7% at the DNA level and 67.8% at the amino acid level) with B 19 parvovirus in the VP2 capsid region and almost no homology with other known parvoviruses (Fig.  3) . These results indicated that we had identified a previously unrecognized SPV that should be included in the Parvovirus family.
Serum samples were tested for the presence ofSPV DNA by PCR using the primers and an internal probe designed from the sequence of the 723-bp cloned insert. No DNA was amplified from the pYT103 control, confirming that the PCR is specific for SPV. Samples from the four anemic monkeys (nos. [1] [2] [3] [4] from the original group of five were positive for SPV DNA (Fig. 4) . Although the samples from the healthy monkey (no. Figure 4 . PCR for SPV. Primers designed from the SPV sequence in Fig. 3 (nucleotides 60-79 , 676-657) were used to amplify a 616-nucleotide fragment (arrow) of SPV in serum samples; product detection was with a 32P end-labeled internal probe (nucleotides 497-515).
(Lanes 1-7) Monkeys nos. 1-7 described in text; (lanes 8-10) (Fig. 2A) ; (lane 12) pYT103 control; (lane 13) water control.
5) (Fig. 2 ) and the two in-contact monkeys (nos. 6 and 7) were negative by dot blot analysis (data not shown), samples from monkeys nos. 6 and 7 were positive by PCR (Fig. 4) . Ofparticular interest was our detection of SPV DNA in a serum sample from a cynomolgus monkey that died at the CMCRC in May 1991 (Fig. 4) . A total of five animals with a history of severe anemia were necropsied at that time, and sera were tested from two of them (Fig. 4) Finally, experimentally infecting monkeys with SPV or B 19 parvovirus could serve as an animal model of human parvovirus infection and should increase understanding of the pathogenesis of disease caused by both the human and simian parvoviruses in their respective natural hosts. In this regard, our finding of dyserythropoiesis in bone marrows from SPVinfected animals is remarkably similar to that of people with congenital dyserythropoietic anemias (CDA), a group ofhereditary refractory anemias. This raises the intriguing question of whether B 19 parvovirus infection may underlie some of the human CDA, or allied conditions such as Diamond-Blackfan anemia. In support of this possibility is our finding of dyserythropoiesis with prominent binucleated and trinucleated erythroblasts, consistent with a diagnosis of CDA type II, in a patient congenitally infected with B19 parvovirus (22a). Other areas in which experimental infection of monkeys with SPV might increase our understanding of human B 19 infections include how the virus is transmitted and in which tissues initial virus replication occurs, the pathogenesis of fetal deaths when infection occurs during pregnancy, the role of B 19 parvovirus in arthropathies, and whether latent infection ofcells or tissues occurs. Studies with SPV in monkeys also may be of value in developing effective vaccination regimes for B 19 parvovirus.
